J. Rolff

发表

QSEA—modelling of genome-wide DNA methylation from sequencing enrichment experiments

H. Sültmann, R. Herwig, I. Fichtner, 2016, Nucleic acids research.

In vitro cultured lung cancer cells are not suitable for animal-based breath biomarker detection

R. Menzel, C. Fischer-Tenhagen, J. Rolff, 2015, Journal of breath research.

Present-day strain rates at the northern end of the ethiopian rift valley

J. Rolff, P. Mohr, A. Girnius, 1978 .

CD28 Co-Stimulus Achieves Superior CAR T Cell Effector Function against Solid Tumors Than 4-1BB Co-Stimulus

T. Blankenstein, U. Höpken, J. Schulte, 2021, Cancers.

Synergistic Antitumour Properties of viscumTT in Alveolar Rhabdomyosarcoma

A. Eggert, J. Rolff, S. Jäger, 2017, Journal of immunology research.

Multiple Active Compounds from Viscum album L. Synergistically Converge to Promote Apoptosis in Ewing Sarcoma

A. Eggert, J. Rolff, S. Jäger, 2016, PloS one.

Predictive In Vivo Models for Oncology.

J. Hoffmann, J. Rolff, D. Behrens, 2016, Handbook of experimental pharmacology.

Patient-derived xenografts of non-small-cell lung cancer: a pre-clinical model to evaluate adjuvant chemotherapy?

I. Fichtner, J. Rolff, M. Becker, 2009, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Response of Patient-Derived Non-Small Cell Lung Cancer Xenografts to Classical and Targeted Therapies Is Not Related to Multidrug Resistance Markers

I. Fichtner, J. Rolff, C. Dorn, 2009, Journal of Oncology.

Therapeutic targeting of ATR in alveolar rhabdomyosarcoma

M. Selbach, P. Mertins, K. Haase, 2022, Nature Communications.

A Natural Combination Extract of Viscum album L. Containing Both Triterpene Acids and Lectins Is Highly Effective against AML In Vivo

A. Eggert, J. Rolff, S. Jäger, 2015, PloS one.

GADD45A and CDKN1A are involved in apoptosis and cell cycle modulatory effects of viscumTT with further inactivation of the STAT3 pathway

A. Eggert, J. Rolff, S. Jäger, 2018, Scientific Reports.

Epigenomic profiling of non-small cell lung cancer xenografts uncover LRP12 DNA methylation as predictive biomarker for carboplatin resistance

H. Lehrach, M. Vingron, M. Odenthal, 2018, Genome Medicine.

Prohibitin promotes de-differentiation and is a potential therapeutic target in neuroblastoma.

A. Kentsis, F. Klironomos, J. Schulte, 2019, JCI insight.

Establishment of Patient-Derived Non–Small Cell Lung Cancer Xenografts as Models for the Identification of Predictive Biomarkers

Michael Becker, Iduna Fichtner, Richie Soong, 2008, Clinical Cancer Research.

Small-Molecule Dual PLK1 and BRD4 Inhibitors are Active Against Preclinical Models of Pediatric Solid Tumors

Shuai Liu, F. Klironomos, J. Schulte, 2019, Translational oncology.

Comparative Profiling of the Novel Epothilone, Sagopilone, in Xenografts Derived from Primary Non–Small Cell Lung Cancer

I. Fichtner, A. Sommer, U. Klar, 2010, Clinical Cancer Research.

Influence of eukaryotic translation initiation factor 6 on non-small cell lung cancer development and progression.

H. Popper, M. Asslaber, C. Regenbrecht, 2018, European journal of cancer.

Activation of AMP-activated protein kinase sensitizes lung cancer cells and H1299 xenografts to erlotinib.

H. Fröhlich, H. Sültmann, R. Herwig, 2014, Lung cancer.

Preclinical Study of a Combination of Erlotinib and Bevacizumab in Early Stages of Unselected Non-Small Cell Lung Cancer Patient-Derived Xenografts

I. Fichtner, J. Hoffmann, J. Rolff, 2016, Targeted Oncology.

Chemoresistance in non-small-cell lung cancer: can multidrug resistance markers predict the response of xenograft lung cancer models to chemotherapy?

I. Fichtner, J. Rolff, G. Leschber, 2011, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

The receptor tyrosine kinase AXL mediates nuclear translocation of the epidermal growth factor receptor

R. Salgia, D. Wheeler, R. Kimple, 2017, Science Signaling.

Investigation of cell culture volatilomes using solid phase micro extraction: Options and pitfalls exemplified with adenocarcinoma cell lines.

I. Fichtner, J. Rolff, I. Nehls, 2015, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Exploiting a PAX3-FOXO1-induced synthetic lethal ATR dependency for rhabdomyosarcoma therapy

M. Selbach, K. Haase, Koshi Imami, 2020, bioRxiv.

GADD45A and CDKN1A are involved in apoptosis and cell cycle modulatory effects of viscumTT with further inactivation of the STAT3 pathway

A. Eggert, J. Rolff, S. Jäger, 2018, Scientific Reports.

Animal models for personalized treatment options.

I. Fichtner, J. Hoffmann, B. Jandrig, 2017, International journal of clinical pharmacology and therapeutics.

Radiosensitisation of U87MG brain tumours by anti-epidermal growth factor receptor monoclonal antibodies

I. Fichtner, E. Montero, J. Rolff, 2009, British Journal of Cancer.

Activation of AMP-activated protein kinase sensitizes lung cancer cells and H1299 xenografts to erlotinib.

H. Fröhlich, H. Sültmann, R. Herwig, 2014, Lung cancer.

In vitro cultured lung cancer cells are not suitable for animal-based breath biomarker detection

R. Menzel, C. Fischer-Tenhagen, J. Rolff, 2015, Journal of breath research.